Edition:
United Kingdom

Cancer Genetics Inc (CGIX.OQ)

CGIX.OQ on NASDAQ Stock Exchange Capital Market

0.93USD
21 May 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.93
Open
$0.93
Day's High
$0.93
Day's Low
$0.93
Volume
1,243
Avg. Vol
96,415
52-wk High
$4.32
52-wk Low
$0.83

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

John Pappajohn

89 2014 Non-Executive Chairman of the Board

John Roberts

59 2018 President, Chief Executive Officer

Igor Gitelman

41 2017 Chief Accounting Officer, Principal Accounting Officer

Rita Shaknovich

50 2015 Medical Director, Vice President - Hematopathology Services

Jane Houldsworth

57 2011 Vice President - Research & Development